HMGB1: A new marker for estimation of the postmortem interval

  • Authors:
    • Kiyoshi Kikuchi
    • Ko-Ichi Kawahara
    • Kamal K. Biswas
    • Takashi Ito
    • Salunya Tancharoen
    • Naoto Shiomi
    • Yoshiro Koda
    • Fumiyo Matsuda
    • Yoko Morimoto
    • Yoko Oyama
    • Kazunori Takenouchi
    • Naoki Miura
    • Noboru Arimura
    • Yuko Nawa
    • Shinichiro Arimura
    • Meng X. Jie
    • Binita Shrestha
    • Masahiro Iwata
    • Kentaro Mera
    • Hisayo Sameshima
    • Yoshiko Ohno
    • Ryuichi Maenosono
    • Yutaka Tajima
    • Hisaaki Uchikado
    • Terukazu Kuramoto
    • Kenji Nakayama
    • Minoru Shigemori
    • Yoshihiro Yoshida
    • Teruto Hashiguchi
    • Ikuro Maruyama
  • View Affiliations

  • Published online on: January 1, 2010     https://doi.org/10.3892/etm_00000019
  • Pages: 109-111
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Estimation of the postmortem interval (PMI) is one of the most important tasks in forensic medicine. Numerous methods have been proposed for the determination of the time since death by chemical means. High mobility group box-1 (HMGB1), a nonhistone DNA-binding protein is released by eukaryotic cells upon necrosis. Postmortem serum levels of HMGB1 of 90 male Wistar rats stored at 4, 14 and 24°C since death were measured by enzyme-linked immunosorbent assay. The serum HMGB1 level showed a time-dependent increase up to seven days at 4°C. At 14°C, the HMGB1 level peaked at day 3, decreased at day 4, and then plateaued. At 24°C, the HMGB1 level peaked at day 2, decreased at day 3, and then plateaued. Our findings suggest that HMGB1 is related to the PMI in rats.

Introduction

In recent years, research associated with forensic medicine has at times been regarded as insufficient and of poor quality, particularly when parameters such as journal impact factors and external findings are taken into account. Forensic medicine involves different tasks as compared with clinical medicine (1). Estimation of the postmortem interval (PMI) is one of the most important tasks in forensic medicine (2). In the last 60 years, numerous methods have been proposed for the determination of the time since death by chemical means (3). Previous contributions have reviewed the historical background of this discipline and important postmortem processes, and have discussed the scientific basis underlying attempts to determine the time interval since death (4). Biochemical markers that help to evaluate the time since death have been investigated. These include protein fractions, urea, creatinine, glucose, iron, potassium, calcium, enzymes, immunohistochemical detection of insulin in pancreatic β-cells, the myo-albumin fraction and the level of strontium-90 calcium analogs (2,513). Using medical techniques such as measurement of body temperature, analyzing the liver, or assessing rigor mortis, the time since death can be accurately measured only for the first two or three days after death (4). The number of studies estimating the PMI has a reverse correlation with its importance and value in practice (14). Therefore, research on estimating the PMI is most important.

High mobility group box-1 (HMGB1) is primarily a nuclear protein present in many eukaryotic cells and has a highly conserved amino-acid sequence among species. HMGB1 appears to have two distinct functions in cellular systems. First, it acts as an intracellular regulator of transcription, having a crucial role in the maintenance of DNA function. Second, HMGB1 translocates to the outside of the nucleus in all eukaryotic cells upon necrosis, and is released from macrophages through activation by lipopolysaccharides (LPS), tumor necrosis factor (TNF)-α, interleukin (IL)-1 and interferon (IFN)-γ (15,16).

Studies demonstrating a role for HMGB1 in the PMI are lacking. Postmortem change induces necrosis, and necrotic cells release HMGB1 (16), so detection of serum HMGB1 exuded from corpus necrotic tissue may be related to PMI. In the present study, the postmortem change in serum HMGB1 in the bodies of dead rats at three environmental temperatures was detected. The aim of our study was to investigate the potential use of serum HMGB1 as an estimation of the PMI. Serum HMGB1 during the postmortem period was analyzed by enzyme-linked immunosorbent assay (ELISA).

Materials and methods

Animal protocol

Animal procedures were conducted with the approval of the Animal Care Committee of the Ethics Board of the Institute of Laboratory Animal Sciences of Kagoshima University (Kagoshima, Japan).

Ninety male Wistar rats (weight, 230–260 g; age, 8 weeks) were purchased from Japan SLC Inc. (Tokyo, Japan). They were maintained on a 12-h light/dark cycle with free access to food and water. Rats were anesthetized with chloral hydrate (400 mg/kg body weight, i.p.). They were sacrificed by cervical dislocation and stored at 4, 14 and 24°C. Room temperature was set at 4 or 24°C, and a water bath (Thermominder SD, Taitec, Saitama, Japan) was set at 14°C for 7 days postmortem. At 0, 0.25, 0.5, 1, 2, 3, 4, 5, 6 and 7 days postmortem, blood was removed from each dead body.

Rat samples

Blood samples were collected from the heart and great vessels at autopsy. Samples were centrifuged immediately for 5 min at 5000 rpm. Serum was stored at −80°C until analysis.

HMGB1 ELISA

The concentration of HMGB1 in serum was measured using an ELISA kit (Shino-Test Corp., Kanagawa, Japan).

Statistical analysis

Statistical analysis was carried out using the Student’s t-test. P<0.05 was considered significant.

Results

Postmortem change induces necrosis, and necrotic cells release HMGB1 (16). In the present study, the postmortem change in serum HMGB1 in the bodies of dead rats at three environmental temperatures was detected. At 24°C, the serum HMGB1 level reached a peak on the second day with a time-dependent decrease in the following days whereas, at 14°C the level reached a peak at day 3 with a plateau in the following days (Fig. 1). The HMGBi level showed a time-dependent increase at 4°C. The standard deviation (SD) of HMGB1 levels was very small; reproducibility was probably high. The increase and decrease in HMGB1 levels at postmortem time was extemely large.

Discussion

Assessment of the PMI by HMGB1 measurement is a useful method. Serum samples of only 10 μl are required, and organs do not need to be homogenized. HMGB1 levels can be obtained in just two days using ELISA. The HMGB1 level in a dead body can be used to estimate the PMI. Postmortem analysis of HMGB1 levels could provide an insight into the biochemical changes that occur after death, and could also present potential indicators for assessment of the PMI.

In live humans, the HMGB1 concentration in blood cells was very low in our preliminary data. In the experiment, blood samples were collected from live humans (n=3). Samples were kept up to 7 days at 24°C. The serum HMGB1 level was detected at 0, 1, 2, 3, 4, 5, 6 and 7 days using ELISA. The HMGB1 level showed a time-dependent increase up to 7 days; the HMGB1 concentration in blood cells was very low (median, 6.24 ng/ml).

The high level of HMGB1 in the bodies of dead rats may have been exuded from necrotic cells in the tissue of the heart and the great vessels, and not released only from blood cells.

HMGB1 has been identified to be a potent pro-inflammatory and cytotoxic cytokine (17). HMGB1 has a critical role in sepsis, cancer, disseminated intravascular coagulation, rheumatoid arthritis, cerebral infarction, myocardial infarction, periodontitis and xenotransplantation (1827). The serum HMGB1 level is elevated in human patients with various diseases. In previous studies, serum HMGB1 levels were elevated in patients with myocardial ischemia (median, 159 ng/ml), cerebral ischemia (median, 218 ng/ml), sepsis (median, 83.7 ng/ml) and pancreatitis (median, 5.4 ng/ml) (19,28,29). The maximal serum HMGB1 level is approximately 200 ng/ml. The level of serum HMGB1 in dead rats is very high, suggesting that the cause of death may not influence postmortem serum HMGB1 levels when estimating the PMI.

Body temperature was not measured in the present study, but postmortem temperature has been reported in several publications (3032).

In recent years, research associated with forensic medicine has sometimes been regarded as insufficient and of poor quality (1). Forensic medicine has been removed as an academic discipline from universities in some countries (33). Yet, forensic medicine has made advances. In addition to traditional invasive ‘body-opening’ autopsy of postmortem investigation in humans, virtual ‘body non-opening’ autopsy has been conducted using CT and MRI (34,35). HMGB1 analysis may be a new method in forensic medicine. The data in the present study demonstrate that this technique may be a major advance in the determination of the time since death, providing reliable semi-quantitative biochemical markers from blood samples as opposed to estimates such as those based on direct measurement of temperature. HMGB1 is a new postmortem marker and could be a tool for the estimation of the PMI in the short- and long-term. Further investigations into the timing and physical factors that affect postmortem levels of HMGB1 in different tissues are essential, but detection of HMGB1 permits the development of techniques for the precise determination of the PMI. Upon further validation, this method could be used in combination with established methods to improve estimation of the PMI.

Acknowledgements

We thank N. Uto, T. Nagasato and T. Morizono for their excellent technical assistance.

References

1. 

Madea B, Saukko P and Musshoff F: Tasks of research in forensic medicine – different study types in clinical research and forensic medicine. Forensic Sci Int. 165:92–97. 2007.

2. 

Thaik-Oo M, Tanaka E, Tsuchiya T, et al: Estimation of postmortem interval from hypoxic inducible levels of vascular endothelial growth factor. J Forensic Sci. 47:186–189. 2002.PubMed/NCBI

3. 

Madea B: Is there recent progress in the estimation of the postmortem interval by means of thanatochemistry? Forensic Sci Int. 151:139–149. 2005. View Article : Google Scholar : PubMed/NCBI

4. 

Amendt J, Krettek R and Zehner R: Forensic entomology. Naturwissenschaften. 91:51–65. 2004. View Article : Google Scholar

5. 

Gallois-Montbrun FG, Barres DR and Durigon M: Postmortem interval estimation by biochemical determination in birds muscle. Forensic Sci Int. 37:189–192. 1988. View Article : Google Scholar : PubMed/NCBI

6. 

Gos T and Raszeja S: Postmortem activity of lactate and malate dehydrogenase in human liver in relation to time after death. Int J Legal Med. 106:25–29. 1993. View Article : Google Scholar : PubMed/NCBI

7. 

Kang S, Kassam N, Gauthier ML and O’Day DH: Post-mortem changes in calmodulin binding proteins in muscle and lung. Forensic Sci Int. 131:140–147. 2003. View Article : Google Scholar : PubMed/NCBI

8. 

Mittmeyer HJ: [Investigations to determine the time of death, late post mortem, by means of electrophoresis of inner organs (author’s translation)]. Z Rechtsmed. 84:47–56. 1979.

9. 

Mittmeyer HJ: [Determination of the myo-albumin content. A possibility to determine the hour of death (author’s translation)]. Z Rechtsmed. 84:233–237. 1980.

10. 

Mittmeyer HJ and Strebel KH: [Experimental examinations on forensic determination of time of death by electrofocusing of soluble muscle protein (author’s translation)]. Z Rechtsmed. 85:235–240. 1980.

11. 

Neis P, Hille R, Paschke M, et al: Strontium90 for determination of time since death. Forensic Sci Int. 99:47–51. 1999. View Article : Google Scholar : PubMed/NCBI

12. 

Sabucedo AJ and Furton KG: Estimation of postmortem interval using the protein marker cardiac Troponin I. Forensic Sci Int. 134:11–16. 2003. View Article : Google Scholar : PubMed/NCBI

13. 

Wehner F, Wehner HD, Schieffer MC and Subke J: Delimitation of the time of death by immunohistochemical detection of insulin in pancreatic beta-cells. Forensic Sci Int. 105:161–169. 1999. View Article : Google Scholar : PubMed/NCBI

14. 

Henssge C and Madea B: Estimation of the time since death. Forensic Sci Int. 165:182–184. 2007. View Article : Google Scholar : PubMed/NCBI

15. 

Ito T, Kawahara K, Nakamura T, et al: High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost. 5:109–116. 2007. View Article : Google Scholar : PubMed/NCBI

16. 

Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:191–195. 2002. View Article : Google Scholar : PubMed/NCBI

17. 

Kawahara K, Tancharoen S, Hashiguchi T, et al: Inhibition of HMGB1 by deep ocean water attenuates endotoxin-induced sepsis. Med Hypotheses. 68:1429–1430. 2007. View Article : Google Scholar : PubMed/NCBI

18. 

Dumitriu IE, Baruah P, Manfredi AA, Bianchi ME and Rovere-Querini P: HMGB1: guiding immunity from within. Trends Immunol. 26:381–387. 2005. View Article : Google Scholar : PubMed/NCBI

19. 

Goldstein RS, Gallowitsch-Puerta M, Yang L, et al: Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock. 25:571–574. 2006. View Article : Google Scholar : PubMed/NCBI

20. 

Inoue K, Kawahara K, Biswas KK, et al: HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol. 16:136–143. 2007. View Article : Google Scholar : PubMed/NCBI

21. 

Kawahara K, Setoyama K, Kikuchi K, et al: HMGB1 release in co-cultures of porcine endothelial and human T cells. Xenotransplantation. 14:636–641. 2007. View Article : Google Scholar : PubMed/NCBI

22. 

Kikuchi K, Kawahara KI, Biswas KK, et al: Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cells. Biochem Biophys Res Commun. 385:132–136. 2009. View Article : Google Scholar : PubMed/NCBI

23. 

Kikuchi K, Kawahara KI, Tancharoen S, et al: The free-radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells. J Pharmacol Exp Ther. 329:865–874. 2009. View Article : Google Scholar : PubMed/NCBI

24. 

Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 5:331–342. 2005. View Article : Google Scholar : PubMed/NCBI

25. 

Morimoto Y, Kawahara KI, Tancharoen S, et al: Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1. J Periodontal Res. 43:76–83. 2008. View Article : Google Scholar : PubMed/NCBI

26. 

Taniguchi N, Kawahara K, Yone K, et al: High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48:971–981. 2003. View Article : Google Scholar : PubMed/NCBI

27. 

Ulloa L and Messmer D: High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 17:189–201. 2006. View Article : Google Scholar : PubMed/NCBI

28. 

Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI

29. 

Yasuda T, Ueda T, Takeyama Y, et al: Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas. 33:359–363. 2006. View Article : Google Scholar : PubMed/NCBI

30. 

Henssge C: Concerning the paper by Mall et al, entitled ‘Temperature-based death time estimation with only partially environment conditions’ (Int J Legal Med (2005) 119: 185–194). Int J Legal Med. 121:822007.PubMed/NCBI

31. 

Henssge C, Althaus L, Bolt J, et al: Experiences with a compound method for estimating the time since death. I. Rectal temperature nomogram for time since death. Int J Legal Med. 113:303–319. 2000. View Article : Google Scholar : PubMed/NCBI

32. 

Mall G, Eckl M, Sinicina I, Peschel O and Hubig M: Temperature-based death time estimation with only partially known environmental conditions. Int J Legal Med. 119:185–194. 2005. View Article : Google Scholar : PubMed/NCBI

33. 

Vanezis P: Forensic medicine: past, present and future. Lancet. 364:8–9. 2004. View Article : Google Scholar

34. 

Dirnhofer R, Jackowski C, Vock P, Potter K and Thali MJ: VIRTOPSY: minimally invasive, imaging-guided virtual autopsy. Radiographics. 26:1305–1333. 2006. View Article : Google Scholar : PubMed/NCBI

35. 

Hayakawa M, Yamamoto S, Motani H, Yajima D, Sato Y and Iwase H: Does imaging technology overcome problems of conventional postmortem examination? A trial of computed tomography imaging for postmortem examination. Int J Legal Med. 120:24–26. 2006. View Article : Google Scholar

Related Articles

Journal Cover

January-February 2010
Volume 1 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kikuchi K, Kawahara K, Biswas KK, Ito T, Tancharoen S, Shiomi N, Koda Y, Matsuda F, Morimoto Y, Oyama Y, Oyama Y, et al: HMGB1: A new marker for estimation of the postmortem interval . Exp Ther Med 1: 109-111, 2010
APA
Kikuchi, K., Kawahara, K., Biswas, K.K., Ito, T., Tancharoen, S., Shiomi, N. ... Maruyama, I. (2010). HMGB1: A new marker for estimation of the postmortem interval . Experimental and Therapeutic Medicine, 1, 109-111. https://doi.org/10.3892/etm_00000019
MLA
Kikuchi, K., Kawahara, K., Biswas, K. K., Ito, T., Tancharoen, S., Shiomi, N., Koda, Y., Matsuda, F., Morimoto, Y., Oyama, Y., Takenouchi, K., Miura, N., Arimura, N., Nawa, Y., Arimura, S., Jie, M. X., Shrestha, B., Iwata, M., Mera, K., Sameshima, H., Ohno, Y., Maenosono, R., Tajima, Y., Uchikado, H., Kuramoto, T., Nakayama, K., Shigemori, M., Yoshida, Y., Hashiguchi, T., Maruyama, I."HMGB1: A new marker for estimation of the postmortem interval ". Experimental and Therapeutic Medicine 1.1 (2010): 109-111.
Chicago
Kikuchi, K., Kawahara, K., Biswas, K. K., Ito, T., Tancharoen, S., Shiomi, N., Koda, Y., Matsuda, F., Morimoto, Y., Oyama, Y., Takenouchi, K., Miura, N., Arimura, N., Nawa, Y., Arimura, S., Jie, M. X., Shrestha, B., Iwata, M., Mera, K., Sameshima, H., Ohno, Y., Maenosono, R., Tajima, Y., Uchikado, H., Kuramoto, T., Nakayama, K., Shigemori, M., Yoshida, Y., Hashiguchi, T., Maruyama, I."HMGB1: A new marker for estimation of the postmortem interval ". Experimental and Therapeutic Medicine 1, no. 1 (2010): 109-111. https://doi.org/10.3892/etm_00000019